This award funds creative early-stage researchers proposing innovative, high-impact projects in any NIH-relevant field, as part of NIH’s High-Risk, High-Reward Research Program.
This award funds highly creative scientists to pursue groundbreaking, high-risk research that could transform key areas of science related to the NIH mission.
This award funds exceptional early-career researchers to launch independent NIH-relevant projects immediately after doctoral or clinical training, bypassing the typical postdoctoral phase.
Funds bold, unconventional research by individuals or teams aiming to transform science, clinical practices, or technology through high-risk, high-reward projects.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIH's R21 grant funds high-risk, early-stage research with potential for breakthroughs in biomedical, behavioral, or clinical fields, excluding clinical trials.